Neutralization of SARS-CoV-2 infection by antibodies targeting diverse epitopes

被引:0
|
作者
Wang, Shusheng [1 ,2 ]
Liao, Yunji [1 ]
Yang, Kaiyong [2 ]
Ma, Hang [1 ]
Song, Zhangyi [1 ,2 ]
Huang, Haiqiu [2 ]
Zhang, Li [2 ]
Wang, Ailing [2 ]
Han, Lei [3 ]
Zhang, Jiawei
Chen, Hui [1 ]
Yin, Haiyang [1 ]
Bian, Yanlin [1 ]
Jiang, Hua [2 ]
Xiao, Xiaodong [2 ]
Xie, Yueqing [2 ]
Yuan, Yunsheng [1 ]
Zhu, Jianwei [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Pharm, Engn Res Ctr Cell & Therapeut Antibody, Minist Educ, Shanghai 200240, Peoples R China
[2] Jecho Labs Inc, Frederick, MD 21704 USA
[3] Jecho Inst Co Ltd, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.gendis.2023.101088
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
    Lihong Liu
    Pengfei Wang
    Manoj S. Nair
    Jian Yu
    Micah Rapp
    Qian Wang
    Yang Luo
    Jasper F.-W. Chan
    Vincent Sahi
    Amir Figueroa
    Xinzheng V. Guo
    Gabriele Cerutti
    Jude Bimela
    Jason Gorman
    Tongqing Zhou
    Zhiwei Chen
    Kwok-Yung Yuen
    Peter D. Kwong
    Joseph G. Sodroski
    Michael T. Yin
    Zizhang Sheng
    Yaoxing Huang
    Lawrence Shapiro
    David D. Ho
    Nature, 2020, 584 : 450 - 456
  • [32] Human neutralizing antibodies elicited by SARS-CoV-2 infection
    Bin Ju
    Qi Zhang
    Jiwan Ge
    Ruoke Wang
    Jing Sun
    Xiangyang Ge
    Jiazhen Yu
    Sisi Shan
    Bing Zhou
    Shuo Song
    Xian Tang
    Jinfang Yu
    Jun Lan
    Jing Yuan
    Haiyan Wang
    Juanjuan Zhao
    Shuye Zhang
    Youchun Wang
    Xuanling Shi
    Lei Liu
    Jincun Zhao
    Xinquan Wang
    Zheng Zhang
    Linqi Zhang
    Nature, 2020, 584 : 115 - 119
  • [33] The humoral response and antibodies against SARS-CoV-2 infection
    Hai Qi
    Bo Liu
    Xinquan Wang
    Linqi Zhang
    Nature Immunology, 2022, 23 : 1008 - 1020
  • [34] Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
    Bekliz, Meriem
    Adea, Kenneth
    Vetter, Pauline
    Eberhardt, Christiane S.
    Hosszu-Fellous, Krisztina
    Vu, Diem-Lan
    Puhach, Olha
    Essaidi-Laziosi, Manel
    Waldvogel-Abramowski, Sophie
    Stephan, Caroline
    L'Huillier, Arnaud G.
    Siegrist, Claire-Anne
    Didierlaurent, Arnaud M.
    Kaiser, Laurent
    Meyer, Benjamin
    Eckerle, Isabella
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [35] SARS-COV-2 INFECTION AND HEMOFILTRATION-TARGETING VIREMIA
    Meece, Lydia
    Park, Angela
    Afroze, Aneesa
    CHEST, 2022, 162 (04) : 507A - 507A
  • [36] The humoral response and antibodies against SARS-CoV-2 infection
    Qi, Hai
    Liu, Bo
    Wang, Xinquan
    Zhang, Linqi
    NATURE IMMUNOLOGY, 2022, 23 (07) : 1008 - 1020
  • [37] IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
    Quinti, Isabella
    Mortari, Eva Piano
    Fernandez Salinas, Ane
    Milito, Cinzia
    Carsetti, Rita
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [38] Human neutralizing antibodies elicited by SARS-CoV-2 infection
    Ju, Bin
    Zhang, Qi
    Ge, Jiwan
    Wang, Ruoke
    Sun, Jing
    Ge, Xiangyang
    Yu, Jiazhen
    Shan, Sisi
    Zhou, Bing
    Song, Shuo
    Tang, Xian
    Yu, Jinfang
    Lan, Jun
    Yuan, Jing
    Wang, Haiyan
    Zhao, Juanjuan
    Zhang, Shuye
    Wang, Youchun
    Shi, Xuanling
    Liu, Lei
    Zhao, Jincun
    Wang, Xinquan
    Zhang, Zheng
    Zhang, Linqi
    NATURE, 2020, 584 (7819) : 115 - +
  • [40] Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
    Meriem Bekliz
    Kenneth Adea
    Pauline Vetter
    Christiane S. Eberhardt
    Krisztina Hosszu-Fellous
    Diem-Lan Vu
    Olha Puhach
    Manel Essaidi-Laziosi
    Sophie Waldvogel-Abramowski
    Caroline Stephan
    Arnaud G. L’Huillier
    Claire-Anne Siegrist
    Arnaud M. Didierlaurent
    Laurent Kaiser
    Benjamin Meyer
    Isabella Eckerle
    Nature Communications, 13